| Patent Number |
Title Of Patent |
Date Issued |
| 8198331 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
June 12, 2012 |
| The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and |
| 7855308 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
December 21, 2010 |
| The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent t |
| 7737137 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
June 15, 2010 |
| Methods for treating a mammal suffering from glucocorticoid-related diseases and conditions, comprising administering to the mammal an effective amount of a selective inhibitor of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme activity, wherein the inhibitor is a compound of form |
| 7511175 |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
March 31, 2009 |
| The present invention relates to compounds which are inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent t |
| 6323231 |
Use of .alpha.1A adrenoceptor agonists with .alpha.1B and .alpha.1D antagonism for the treatment |
November 27, 2001 |
| The following disclosure relates to a method of treating incontinence with a compound having a specific .alpha..sub.1A adrenoceptor profile. |
